Clinical trials
Phase 3 Hematologic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Fred Hutchinson Cancer Center | 2 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| Charite University, Berlin, Germany | 1 |
| Kiadis Pharma | 1 |
| Kura Oncology, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 12 |
| Multiple Myeloma | 5 |
| Leukemia | 4 |
| Bone Marrow Diseases | 3 |
| Hodgkin Disease | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Hematologic Diseases | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.